Opinion|Videos|July 30, 2024
Role of Pharmacists in Improving Vaccine Uptake
An expert on RSV vaccination provides insights on barriers that prevent the uptake of RSV vaccines and preventative measure in the pipeline for RSV.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What barriers prevent the uptake of RSV vaccines? How can these barriers be addressed and vaccine uptake be improved by pharmacists?
- What types of preventative measures (i.e. additional vaccines, expanded indications or populations) are in the pipeline for RSV?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Patients reported that zongertinib resulted in improvements in physical functioning within 1 week of initiating therapy.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
The first AHA endocarditis update in 11 years expands outpatient options, with a bigger role for pharmacists.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
Investigational inhaled stem cells for COPD raise questions about lasting clinical benefit and the pharmacy controls needed to deliver a living-cell product through a nebulizer.
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague, and which antibiotics the CDC recommends.
In an interview with Pharmacy Times, Abdulkader Rahmo, PhD, discusses investigational inhaled cell therapy for COPD, the evidence needed to establish lasting clinical benefit, and pharmacists’ potential role in its delivery.
The gap is not a paperwork inconvenience—it is a cash flow problem with clinical consequences.
Advertisement
Advertisement